(Q47908471)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Hematopoietic stem cell transplantation for hematological malignancies in Europe (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Francesco Frassoni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

A Gratwohl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Baldomero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Niederwieser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Schmitz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Urbano-Ispizua

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT)

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Working Parties Acute (ALWP) Chronic Leukemias (CLWP)

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Lymphoma Working Party

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

941-959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750709%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402896

3 November 2019

exact match

0 references

cites work

Haemopoietic stem-cell transplantation: recent progress and future promise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an American view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a European view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

High-dose chemotherapy and autologous stem cell transplantation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Immunotherapy of cancer with alloreactive lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Non-myeloablative stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Autologous and allogeneic transplantation for aggressive NHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Autologous stem cell transplantation in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Stem cell transplant numbers decline; research continues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Transplantation in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402896

7 January 2021